Company logo.png
Pharmazz Inc. and Sun Pharma enter into licensing agreement for introducing Tyvalzi™ (Sovateltide) in India
14 sept. 2023 00h30 HE | Pharmazz, Inc.
Sovateltide is a first of its kind drug to treat acute cerebral ischemic stroke that can be administered up to 24 hours after the onset of symptomsIndia is the first global territory where Tyvalzi™...
Global Stroke Care Continuum Research Report 2023: Trends, Growth Opportunities, and Forecasts 2023-2027 with 2022 as the Base Year
04 août 2023 09h33 HE | Research and Markets
Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Stroke Care Continuum: Trends, Growth Opportunities, and Forecasts" report has been added to's offering. This study...
Neurocritical AI solution to be deployed into A&E at Milton Keynes University Hospital NHS Foundation Trust
01 août 2023 03h15 HE | Blackford
EDINBURGH, Scotland, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Blackford, the pioneering strategic AI platform and solutions provider, has partnered with, a leading provider of artificial...
iHS-logo (1).jpg
AI-Based Health Screening Company iHealthScreen Reaches $150K in Investments
26 juin 2023 20h25 HE | iHealthScreen Inc.
RICHMOND HILL, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- AI-based health screening company iHealthScreen recently announced raising $150,000 in investments on StartEngine. To date, the company has...
Anthos Logo Transparent.png
Anthos Therapeutics Supported Global Survey of 3000+ Patients Prescribed Anticoagulants Detailing Impact of Patient-Relevant Bleeding (PRB) Presented at ISTH 2023
26 juin 2023 07h00 HE | Anthos Therapeutics
Patient-Centric Survey Conducted in Collaborationwith and the National Blood Clot Alliance Findings Suggest “Patient-Relevant Bleeding” More Accurate Than Current Terminology,...
Algernon Logo 1.png
Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Stroke and TBI Studies
05 juin 2023 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...
Logo transparent PNG.png
PathMaker Neurosystems Receives $200,000 START Award from MassVentures
05 juin 2023 06h00 HE | PathMaker Neurosystems Inc.
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
Company logo.png
Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India for Acute Cerebral Ischemic Stroke Patients
31 mai 2023 09h19 HE | Pharmazz, Inc.
The proportion of acute cerebral ischemic stroke patients with the mRS of 0-2 on day 90 post-randomization was statistically significant (p=0.002) Sovateltide is a first-in-class drug that...
Anthos Logo Transparent.png
New Assessment Scale to Measure Adherence to Oral Anticoagulants Based on Impact of Patient Relevant Bleeding in Atrial Fibrillation Presented at ISPOR 2023
09 mai 2023 09h45 HE | Anthos Therapeutics
Anticoagulant Bleeding Burden Adherence Confidence Assessment Scale [ABBA-CAS] Created to Better Address an Important Treatment Gap in the Management of Atrial Fibrillation (AF) and Bring Patient...
Anthos Logo Transparent.png
New Assessment Scale to Capture Patient Relevant Bleeding to be Presented at ISPOR 2023
05 mai 2023 08h00 HE | Anthos Therapeutics
Additional presentation spotlights GARDENIA registry design in patientswith atrial fibrillation and atrial flutter Early Cost-Effectiveness Modeling for Patients with Atrial Fibrillation and Cancer...